Clinician Awareness and Interest in Blood Tests for Alzheimer's Disease
Author Information
Author(s): Tracy Karen, Wood Julie, Tiede Ben, Scholler Emily
Primary Institution: Gerontological Society of America
Hypothesis
What are clinicians' perceptions and experiences with blood-based biomarkers for diagnosing Alzheimer's disease?
Conclusion
Clinicians recognize the potential of blood tests for Alzheimer's diagnosis but need more information to effectively use them in practice.
Supporting Evidence
- Early detection of dementia is valuable for treatment.
- Current diagnostic methods like PET scans have limitations.
- Blood tests are emerging as a new tool for Alzheimer's diagnosis.
Takeaway
Doctors are learning about new blood tests that can help find Alzheimer's disease earlier, but they need more training to use these tests well.
Methodology
Surveys were issued to members of the American Academy of Family Physicians and the Gerontological Society of America.
Limitations
The study relies on self-reported perceptions and experiences of clinicians.
Participant Demographics
Members of the American Academy of Family Physicians and the Gerontological Society of America.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website